Research/art/teacher profile of a person
Name and surname:
doc. MUDr. Mária Bucová, CSc.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Bucová
I.2 - Name
Mária
I.3 - Degrees
assoc. professor, M.D., Ph.D., extraordinary profesor
I.4 - Year of birth
1958
I.5 - Name of the workplace
Institute of Immunology, Faculty of Medicine, Comenius University, Bratislava
I.6 - Address of the workplace
Faculty of Medicine Comenius university, Špitálska 24, 813 72 Bratislava
I.7 - Position
associated professor
I.8 - E-mail address
bucova1@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/3101
I.10 - Name of the study field in which a person works at the university
Immunology
I.11 - ORCID iD
0000-0003-4742-3505

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University, Bratislava, Slovakia
II.b - Year
1983
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University, Bratislava
II.b - Year
1989
II.c - Study field and programme
Immunology
II.4 - Associate professor
II.a - Name of the university or institution
Faculty of Medicine, Comenius University, Bratislava
II.b - Year
2008
II.c - Study field and programme
Immunology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
internal aspirant (internal doctoral student) Department of Medical Microbiology and Immunology, Faculty of Medicine, Comenius University, Bratislava 1983-1987
assistent Department of Medical Microbiology and Immunology, Faculty of Medicine, Comenius University, Bratislava 1988-1988
assistant professor Department of Medical Microbiology and Immunology, Faculty of Medicine, Comenius University, Bratislava 1988-1992
assistant professor Institute of Immunology, Faculty of Medicine, Comenius University, Bratislava 1992-2008
Associated professor Institute of immunology, Faculty of Medicine, Comenius University, Bratislava 2008- up to now

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Immunology General Medicine II General Medicine
Dentistry Immunology II Dentistry
New Trends in Medical Microbiology and Immunology All doctoral study programmes at Faculty of Medicine Comenius University, Bratislava III General Medicine and Dentistry
Dissertation I and II, Dissertation exam. Defense of the dissertation. Immunology III General Medicine
Clinical Immunology General Medicine II General Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
Immunology II General Medicine
Immunology II Dentistry
Clinical Immunology II General Medicine
New Trends in Medical Microbiology and Immunology III All doctoral study programmes in Faculty of Medicine, Comenius University, Bratislava
Dissertation I and II, Dissertation exam. Defense of the dissertation. III General Medicine
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
3
V.4.c - Dissertation (third degree)
3
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
1
V.4.b - Diploma (second degree)
30
V.4.c - Dissertation (third degree)
6
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
314
VI.1.b - Over the last six years
72 = 27 publications + 45 abstracts from conferences
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
82
VI.1.b - Over the last six years
26
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
597
VI.1.b - Over the last six years
291
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
597
VI.1.b - Over the last six years
291
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
41
VI.1.b - Over the last six years
4 (pandemy)
VI.2 - The most significant research/artistic/other outputs
1

Bucova, M; Lietava, J; (...); Petrek, M. Association of MCP-1-2518 A/G Single Nucleotide Polymorphism with the Serum Level of CRP in Slovak Patients with Ischemic Heart Disease, Angina Pectoris, and Hypertension. 2009 MEDIATORS OF INFLAMMATION 2009 IF=4,4, Q2

2

Bucova M., Suchankova M., Dzurilla M., Vrlik M., Novosadova H., Tedlova E., Urban S, Hornakova E., Seligova M., Durmanova V., Penz P., Javor J., Paulovicova E. Inflammatory Marker sTREM-1 Reflects the Clinical Stage and Respiratory Tract Obstruction in Allergic Asthma Bronchiale Patients and Correlates with Number of Neutrophils. Mediators Inflamm . 2012:2012:628754. doi: 10.1155/2012/628754. Epub 2012 Jul 5. Q2; IF=4,4

 

3

Kluckova K., Kozak J., Szaboova K., Rychly B., Svajdler M., Suchankova M., Tibenska E., Filova B., Steno J., Matejcik V., Homolova M., Bucova, M. TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients. Mediators of Inflammation; jul 1 2020; 2020. DOI10.1155/2020/1798147; Q2; IF= 4,6.

4

Suchankova M, Urban J, Ganovska M, Tibenska E, Szaboova K, Tedlova E, Sandor F, Majer I, Bobovcak M, Jonner I, Konig B, Bucova M. TREM-1 and TREM-2 Expression on CD14+ Cells in Bronchoalveolar Lavage Fluid in Pulmonary Sarcoidosis and Hypersensitivity Pneumonitis in the Context of T Cell Immune Response. Mediators Inflamm. 2020 May 14;2020:9501617. doi: 10.1155/2020/9501617. eCollection 2020. Q2; IF= 4,6. 

5

Bucova M., Kluckova K., Kozak J., Rychly B., Suchankova M., Svajdler M., Matejcik V., Steno J., Zsemlye E., Durmanova V.  HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients. Diagnostics May 2022; Volume12; Issue5. DOI10.3390/diagnostics12051099. Q2, IF 3,6.

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Durmanova, V., Mikolaskova, I., Zsemlye, E., Ocenasova, A., Bandzuchova, H., Suchankova, M., Kollarik, B., Palacka, P., Zvarik, M., Bucova, M., Hunakova, L. Association of HLA-G Expression, Its Genetic Variants and Related Neuro-Immunomodulation with Characteristics of Bladder Carcinoma. CANCERS Volume16 Issue22, DOI10.3390/cancers16223877, Q1. IF=4,5

2

Kluckova K., Kozak J., Szaboova K., Rychly B., Svajdler M., Suchankova M., Tibenska E., Filova B., Steno J., Matejcik V., Homolova M., Bucova, M. TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients. Mediators of Inflammation; jul 1 2020; 2020. DOI10.1155/2020/1798147; Q2; IF= 4,6.

3

Bucova M., Kluckova K., Kozak J., Rychly B., Suchankova M., Svajdler M., Matejcik V., Steno J., Zsemlye E., Durmanova V.  HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients. Diagnostics May 2022; Volume12; Issue5. DOI10.3390/diagnostics12051099. Q2, IF= 3,6.

4

Suchankova, M, Urban J, Ganovska M, Tibenska E, Szaboova K, Tedlova E, Sandor F, Majer I, Bobovcak M, Jonner I, Konig B, Bucova M. TREM-1 and TREM-2 Expression on CD14+ Cells in Bronchoalveolar Lavage Fluid in Pulmonary Sarcoidosis and Hypersensitivity Pneumonitis in the Context of T Cell Immune Response. Mediators Inflamm. 2020 May 14;2020:9501617. doi: 10.1155/2020/9501617. eCollection 2020. Q2; IF= 4,6.

5

Bucova M., Majernikova B., Durmanova V., Cudrakova D., Gmitterova K., Lisa I., Klimova E., Kluckova K., Buc M. HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis. Neurol Sci. 2020 Mar;41(3):599-604. doi: 10.1007/s10072-019-04136-3. Epub 2019 Nov 14. PMID: 31728855  Q2; IF= 3,3.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Bucova, M; Lietava, J; (...); Petrek, M. Association of MCP-1-2518 A/G Single Nucleotide Polymorphism with the Serum Level of CRP in Slovak Patients with Ischemic Heart Disease, Angina Pectoris, and Hypertension. 2009 MEDIATORS OF INFLAMMATION 2009 IF=4,4, Q2

 Zopár citácií:

1. Wang, YY; Zhang, WL; (...); Hui, RT. Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: A meta-analysis. Nov 2011 ATHEROSCLEROSIS 219 (1) , pp.224-230IF=4,9; Q1

2. Dommel, S., Blüher, M.Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State? INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Vol 22, Issue 3 DOI10.3390/ijms22031500  IF=4,9; Q1

3. Dusi, V; Ghidoni, A; (...); Calvillo, L. Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems. 2016 MEDIATORS OF INFLAMMATION 2016. IF=4,4; Q2

4. Jing, YL; Zhu, DL; (...); Shen, SM. Monocyte chemoattractant protein 1-2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population. Feb 20 2011. CLINICA CHIMICA ACTA412 (5-6) , pp.466-469. IF=3,2; Q1/Q2

5. Amorim, FG; Campagnaro, BP; (...); Meyrelles, SS. Association of Interleukin-6 Gene Polymorphism With Angina Pectoris. Oct 2011 ANGIOLOGY 62 (7) , pp.549-553.IF=2,6; Q2

2

Bucova M., Suchankova M., Dzurilla M., Vrlik M., Novosadova H., Tedlova E., Urban S, Hornakova E., Seligova M., Durmanova V., Penz P., Javor J., Paulovicova E. Inflammatory Marker sTREM-1 Reflects the Clinical Stage and Respiratory Tract Obstruction in Allergic Asthma Bronchiale Patients and Correlates with Number of Neutrophils. Mediators Inflamm . 2012:2012:628754. doi: 10.1155/2012/628754. Epub 2012 Jul 5. Q2; IF=4,4

 Zopár citácií:

1. Croteau-Chonka, DC; Qiu, WL; (...); Raby, BA. Gene Expression Profiling in Blood Provides Reproducible Molecular Insights into Asthma Control. AMERICAN JOURNAL of RESPIRATORY and CRITICAL CARE MEDICINE 2017 Jan 15;195(2):179-188. doi: 10.1164/rccm.201601-0107OC.Jan 15 2017; 195 (2) , pp.179-188. Q1, IF= 24,7

2.Sánchez-Ovando, S., Simpson, J.L., Barker, D., Baines, K.J., Wark, P.A.B. Transcriptomics of biopsies identifies novel genes and pathways linked to neutrophilic inflammation in severe asthma. 2021         Clinical and Experimental Allergy 51(10), pp. 1279-1294. Q1; IF=6,3.

3.Whole blood transcriptional variations between responders and non-responders in asthma patients receiving omalizumab Upchurch, K., Wiest, M., Cardenas, J., (...), Turner, J., Oh, S. 2020   Clinical and Experimental Allergy 50(9), pp. 1017-1034. Q1, IF=6,3.

4.de Oliveira Matos, A., dos Santos Dantas, P.H., Figueira Marques Silva-Sales, M., Sales-Campos, H. The role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infections 2020 Critical Reviews in Microbiology 46(3), pp. 237-252. Q1; IF=6

5.Karagianni, A.E., Kurian, D., Cillán-Garcia, E., (...), Wishart, T.M., Pirie, R.S. Training associated alterations in equine respiratory immunity using a multiomics comparative approach 2022     Scientific Reports 12(1),427. Q1, IF=3,8

3

Kluckova K., Kozak J., Szaboova K., Rychly B., Svajdler M., Suchankova M., Tibenska E., Filova B., Steno J., Matejcik V., Homolova M., Bucova, M. TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients. Mediators of Inflammation; jul 1 2020; 2020. DOI10.1155/2020/1798147; Q2; IF= 4,6

Zopár citácií:

1. Sun, R; Han, RW; (...); Kim, AH. TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma. SCIENCE ADVANCES 2023 May 12;9(19):eade3559. doi: 10.1126/sciadv.ade3559. Epub 2023 May 12. Q1, IF (2022)= 13,6

2. Shen, P; Zhang, TY; (...); Duan, YN. Recombinant P40 protein of Schistosoma japonicum inhibits TREM-1 expression in RAW264.7 cells via FOXO3a May 2022. BIOMED PHARMACOTHER. 2022 May:149:112826. doi: 10.1016/j.biopha.2022.112826. Epub 2022 Mar 17. Q1, IF= 7,5

3. Cheng, X; Wang, XW; (...); Peng, WJ. Systematic Pan-Cancer Analysis Identifies. TREM2 as an Immunological and Prognostic Biomarker. FRONTIERS IN IMMUNOLOGY. Front Immunol. 2021 Feb 17:12:646523. doi: 10.3389/fimmu.2021.646523. eCollection 2021. Q1. IF= 7,3

4. Singh, H; Rai, V; (...); Agrawal, DK. Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015-2020 updates. EXPERT OPINION ON THERAPEUTIC PATENTS. 2021 Jun;31(6):549-561. doi: 10.1080/13543776.2021.1883587. Epub 2021 Feb 8.  Q1, IF=6,6

5. Cao, YH; Wang, YW; (...); Fu, C. The ratio of urinary TREM-1/TREM-2 mRNA expression in chronic kidney disease and renal fibrosis. Jan 1 2021 ANNALS OF MEDICINE 53 (1) , pp.1010-1018; IF=4,9; Q1

4

Bucova M., Majernikova B., Durmanova V., Cudrakova D., Gmitterova K., Lisa I., Klimova E., Kluckova K., Buc M. HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis. Neurol Sci. 2020 Mar;41(3):599-604. doi: 10.1007/s10072-019-04136-3. Epub 2019 Nov 14. PMID: 31728855  Q2; IF= 3,3

 Zopár citácií:

1. Mo, JL; Hu, J and Cheng, XL. The role of high mobility group box 1 in neuroinflammatory related diseases. BIOMEDICINE & PHARMACOTHERAPY. 2023 May:161:114541. doi: 10.1016/j.biopha.2023.114541. Q1, IF= 7,5

2.Duarte, LF; Villalobos, V; (...); Gonzalez, PA. Asymptomatic herpes simplex virus brain infection elicits cellular senescence phenotypes in the central nervous system of mice suffering multiple sclerosis-like disease. Jul 4 2024 COMMUNICATIONS BIOLOGY 7 (1). IF=5,2; Q1

3.Mills, J; Ladner, L; (...); Theus, MH. Cross-Talk and Subset Control of Microglia and Associated Myeloid Cells in Neurological Disorders. Nov 2022, CELLS, 2022 Oct 25;11(21):3364. doi: 10.3390/cells11213364.Q2, IF= 6,6

4. Safavynia, SA; Goldstein, PA and Evered, LA. Mitigation of perioperative neurocognitive disorders: A holistic approach. FRONTIERS IN AGING NEUROSCIENCE, 2022 Jul 27:14:949148. doi: 10.3389/fnagi.2022.949148 Q1, 5,3.

5.Ikram, FZ; Arulsamy, A; (...); Shaikh, MF. The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review 2022 CURRENT NEUROPHARMACOLOGY 20 (11) , pp.2221-2245. Q1, IF=4,8

6.Mo, JL; Hu, J and Cheng, XL. The role of high mobility group box 1 in neuroinflammatory related diseases. BIOMEDICINE & PHARMACOTHERAPY. 2023 May:161:114541. doi: 10.1016/j.biopha.2023.114541. Q1, IF= 6,9.

7. Mohammad, G and Kowluru, RA. Involvement of High Mobility Group Box I Protein in Optic Nerve Damage in Diabetes. 2022EYE AND BRAIN 14 , pp.59-69. Q1, IF=3,1 

5

 Urban J., Suchankova M., Ganovska M., Leksa V., Sandor F., Tedlova E., Konig, B, Bucova, M. The role of CX3CL1 and Adam17 in pathogenesis of diffuse parenchymal lung diseases. Diagnostics Vol 11, Issue 2021 Article number 1074 IF=3, 9; Q1

 Zopár citácií:

 1. Schwartz, J., Capistrano, K.J., Gluck, J., Hezarkhani, A., Naqvi, A.R. SARS-CoV-2, periodontal pathogens, and host factors: The trinity of oral post-acute sequelae of COVID-19. Reviews in Medical Virology 2024, 34(3),e2543 IF=9; Q1

2. Akdeniz, Y.S., Özkan, S. New markers in chronic obstructive pulmonary disease 2024. Advances in Clinical Chemistry 123, pp. 1-63 IF=9; Q1

3. Alarcón-Sánchez, M.A., Becerra-Ruiz, J.S., Guerrero-Velázquez, C., Mosaddad, S.A., Heboyan, A. The role of the CX3CL1/CX3CR1 axis as potential inflammatory biomarkers in subjects with periodontitis and rheumatoid arthritis: A systematic review. 2024 Immunity, Inflammation and Disease. 12(2),e1181 IF=3,1; Q3

4. Hu, H., Yang, H., Liu, Y., Yan, B. Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System 2022.   Frontiers in Medicine. 8,833114 IF=3,1; Q1

 

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

VEGA 1/0426/24 - Molecular mechanisms of fibrotic and inflammatory processes of diffuse parenchymal lung diseases - analyzes of defined markers in bronchoalveolar lavages and their significance in clinical practice

2024 - 2027

Project representative

Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences

2

VEGA 1/0758/20 - Diffuse parenchymal lung diseases - inflammation, immunological mechanisms and determination of novel markers for diagnosis and differential diagnosis

2020 - 2022

Project leader

Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences

3

VEGA 1/0212/17: TREM-1, TREM-2 tests as new diagnostic and differential-diagnostic tests for sarcoidosis and other diffuse parenchymal lung diseases. Attempt at immunological classification of pulmonary diseases.

2017 - 2019

Project leader

Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences.

4

APVV-22-0231 - Therapeutic potential of stress-reducing intervention in complex cancer care.

2023 - 2027

Coauthor

Slovak Research and Development Agency

5

„APVV-21-0197: Investigation of the impact of stress on the course of cancer (project leader: Božena Smolková, MSc., PhD.)

 2022-2026

Coauthor

Slovak Research and Development Agency

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
The main organizer of the first days of young Czechoslovak immunologists under the age of 35 in Tatranská Lomnica Slovak Immunologic Society october 1988
Organizer of regular monthly seminars of the Slovak Immunological Society and the Society of Slovak Allergiologists and Immunologists Slovak Immunologic Society (SIS) roky 1995 - 2000
Member of the Committee of the Slovak Immunological Society Slovak Immunologic Society (SIS) 2012- up to now
Member of the working group of the Czech and Slovak forum for sepsis and MODS Czech and Slovak forum for sepsis and MODS in Ostrava, Czech republic 2003 - 2014

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Department of Immunology, Faculty of Medicine, Palacky University Olomouc Faculty of Medicine, Palacky University, Olomouc, Czech Republic 5 - times one week study stay during years 2005, 2006, 2007, 2008, 2009 Under the leadership of prof. Dr. Martin Petřek, CSc., and assoc. prof. Dr. František Mrázek, PhD.)
Department of Immunology, Faculty of Medicine, Palacky University Olomouc; and Institute of Immunogenetics and Immunogenomics Faculty of Medicine, Palacky University, Olomouc, Czech Republic 2009 - up to now; Repeated participation in PhD and assoc. prof. defenses as opponent of theses Dean office of Faculty of Medicine, Palacky University, Olomouc, Czech Republic

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Co-authore four university scripts and four textbooks.


Certification in Medical Microbiology, obtained in the year 1989.


Awards for publications:


1., Awarding the work of Bucova M., Suchankova M., et al. (Mediators of Inflammation, 2012) from "Word Biomedical Frontiers" for an innovative approach and potential significant impact in diagnostics and therapy


2., Appreciation of the work of the authors Suchankova M., Bucova M, et al. (Respirology, 2013) for the innovative approach and special interest of the drug development sector ("Global Medical Discovery").


3., The Literary Fund awarded the "Premium for scientific and professional literature for the year 2006" for the book: Kresánek, Furková K. et al. (Bucová M. - co-author) Adolescent medicine. Martin, Osveta 2006, 375 p.


4th, 2nd place for an original publication in the journal Cardiology in 2005 (work: Pecháň I, Bucová M, Daňová K et al. Cytokine levels in patients before and after closure of an atrial septal defect (type II) with an Amplatz occluder. Cardiol 2005; 14(6):313-318.



1. Student management within ŠVOČ ( student scientific activity) - Terézia Pinčíková - in 2005 - 1st place in the paraclinical section at ŠVOČ at Faculty of Medicine Comenius University in Bratislava.


2. Leading students within the PhD conference - 2 times 2nd place at the PhD conference in Bratislava (2011 and 2013). (doctoral student Magda Suchánková, MD)


3. Leading students within the PhD conference - r. 2018 – doctoral student, 3rd place in the faculty round of the PhD conference (Maruščáková L.)


4. Leading students within the PhD conference - 2 times 2nd place at the PhD conference in Bratislava (years 2019, 2021); (doctoral student: MUDr. Ján Urban)


5. Leading students within the PhD conference - 2019: 2nd place at the PhD conference in Bratislava (doctoral student Kristína Klučková, MD)


6. Leading doctoral student : year 2019 - first place (Urban Ján) in Olomouc at the 21st Congress of the Czech and Slovak Pneumological and Physiological Society

Date of last update
2025-01-30